Medetomidine Withdrawal: Symptoms, Risks, and How It Differs From Xylazine Withdrawal
Medically reviewed by Harsh Brar, FNP-C.
Medetomidine withdrawal is a rapid and sometimes severe reaction that can follow stopping or cutting back after using medetomidine, a veterinary sedative now found in the illicit opioid supply. Heart rate and blood pressure can spike, with vomiting and tremor. Severe symptoms need urgent medical care.
If you are researching care for opioid withdrawal, you can read how In-Home Opioid Detox works.
| Update, October 20, 2026
This guide reflects the CDC Health Advisory of April 2, 2026, Philadelphia’s March 2026 public health update, and hospital studies published through September 2026. Medetomidine guidance changes quickly, so we revise this page as new information is released. |
| If this is an emergency
Call 911 first if someone is unresponsive, has slow or stopped breathing, has chest pain, cannot stop vomiting, or keeps drifting in and out of awareness. If you suspect a medetomidine or fentanyl overdose, use naloxone if you have it and stay until responders arrive. For distress, or to ask for help with drug use, call or text 988. |
Table of Contents:
What is medetomidine, and why is it in the drug supply?
Medetomidine is a sedative approved for dogs. Medetomidine belongs to the alpha-2 agonist family, like xylazine and clonidine, and CDC describes it as more potent and longer-acting than both. Philadelphia health officials estimate medetomidine is 100 to 200 times more potent than xylazine. Its relative dexmedetomidine is approved to sedate people in hospitals, which is why the names get mixed up.
Street medetomidine is not diverted from pharmacies or clinics. CDC reports that lab testing of street medetomidine points to clandestine manufacturing. Federal forensic reports of medetomidine rose from 247 in 2023 to 8,233 in 2025, mostly in the Northeast and Midwest, though still under 1 percent of all drug reports. Local rates can be far higher: in Philadelphia, medetomidine appeared in 90 percent of street opioid samples by March 2026, up from 29 percent in May 2024.
Medetomidine is typically mixed into products sold as fentanyl, so people may not know it is there. You may hear it called “rhino tranq.” For the wider picture, see our overview of emerging substances and home detox considerations.
How is medetomidine withdrawal different from xylazine withdrawal?
Xylazine and medetomidine are close cousins that show up alongside fentanyl. Both cause deep sedation, and naloxone does not reverse the sedation from either. They differ in skin damage and in withdrawal.
| Xylazine | Medetomidine | Nitazenes | |
|---|---|---|---|
| What it is | Veterinary sedative, not approved for humans. | Veterinary sedative, more potent and longer-acting. Not approved for humans. | Very potent synthetic opioids. |
| Overdose signs | Deep, prolonged sedation. | Prolonged sedation, very slow heart rate, low blood pressure. | Slowed or stopped breathing. |
| Does naloxone help? | Restores breathing from opioids, not xylazine sedation. | Restores breathing from opioids such as fentanyl, not medetomidine sedation. | Works, but more than one dose may be needed. |
| Skin wounds | Associated with deep wounds. | Not linked to wounds so far. | Not a feature. |
| Withdrawal | Anxiety, irritability, low mood. Not relieved by opioids. | Can be severe: fast heart rate, high blood pressure, vomiting, tremor. | Limited data. Opioid withdrawal principles apply. |
| Evidence strength | Established for overdose and wounds, limited for withdrawal. | Emerging: case series and federal advisories. | Emerging: small studies. |
Xylazine withdrawal is generally described as anxiety, irritability, and low mood, and opioids do not relieve it. Medetomidine withdrawal looks different. Philadelphia clinicians called it distinct from both fentanyl and xylazine withdrawal, driven by a surge in heart rate and blood pressure, and local emergency visits for withdrawal rose while visits for skin infections fell after medetomidine arrived. The evidence on medetomidine is mostly case series and surveillance data, so details will shift. Nitazenes are a different risk altogether, covered in our guide to the new synthetic opioid you should know about.
What are the medetomidine withdrawal symptoms, and when do they start?
CDC compares medetomidine withdrawal to the rebound that can follow stopping clonidine, a related alpha-2 medication. For background, see how clonidine is used in opioid withdrawal care. Hospitals describe the symptoms by body system.
| Body system | What can happen |
|---|---|
| Heart and blood pressure | Fast heart rate (above 100 per CDC), severe high blood pressure (readings above 180/100 cited in Philadelphia guidance), chest pain. |
| Stomach | Nausea and vomiting that will not settle. |
| Nervous system | Tremor, anxiety, restlessness, fluctuating alertness, sometimes delirium. |
| Whole body | Heavy sweating. Clinicians may find low potassium, acid build-up in the blood, and heart rhythm changes. |
| Serious complications | Heart muscle injury, including non-ST elevation myocardial infarction, and posterior reversible encephalopathy syndrome (PRES). Seizures are uncommon. |
Medetomidine slows the heart during intoxication, and in withdrawal the pattern flips to a racing heart and high blood pressure, which helps clinicians tell the two apart. Because medetomidine is usually mixed with fentanyl, opioid withdrawal can happen at the same time.
Medetomidine withdrawal onset is fast. CDC says symptoms may begin within hours of the last use and peak 18 to 36 hours later. A 2026 clinical therapy update puts onset at about 4 to 6 hours in regular users, and Canadian interim guidance says 2 to 6 hours, often before opioid withdrawal begins.
How long does medetomidine withdrawal last?
No one knows with confidence yet, because the evidence is new. Canadian interim guidance, described as emerging practice rather than a standard, says mild to moderate medetomidine withdrawal lasts about 12 to 48 hours and severe withdrawal about 3 days. In a Pittsburgh report following 10 patients in detail, the median hospital stay was about 93 hours. Treat these as rough ranges: duration depends on the person, how much and how long they used, and whether other withdrawal is happening too.
Why can medetomidine withdrawal be risky?
CDC reports that severe medetomidine withdrawal can require emergency or intensive care, and that heart attack and posterior reversible encephalopathy syndrome have been associated with it. Seizures and hallucinations were infrequent with medetomidine withdrawal in the Philadelphia report. Across three Philadelphia health systems, 165 patients with suspected medetomidine withdrawal were hospitalized between September 2024 and January 2025, all with fentanyl withdrawal and severe autonomic dysfunction. In a larger Philadelphia study of 209 patients, 77.5 percent needed intensive care, 20 percent were intubated, and about one in three left before treatment was complete.
Newer work points the same way. Philadelphia clinicians reported that a standard opioid withdrawal protocol became less effective once medetomidine arrived, with intensive care admission at about double the earlier rate, and a September 2026 JAMA Internal Medicine study found dexmedetomidine use and ICU admissions rose sharply at two hospitals. Not everyone will have the most severe course, but severe symptoms deserve prompt evaluation. Most medetomidine evidence comes from case series and retrospective studies, so read it as a serious warning, not a precise forecast.
When should you call 911 or go to the emergency department?
Call 911 or go to the nearest emergency department for chest pain, vomiting that will not stop, going in and out of awareness, or any severe medetomidine withdrawal symptoms. Clinicians weigh readings such as blood pressure above 180/100 or a heart rate above 100, but those are not a home test, and no one needs to measure anything before seeking help.
Overdose is a separate emergency. Because fentanyl is involved in most overdoses where medetomidine is present, CDC advises giving naloxone to restore breathing and repeating it as needed. Naloxone will not reverse medetomidine sedation, so focus on breathing rather than responsiveness, use the recovery position, call 911, and stay until help arrives. A step-by-step walkthrough is in our guide on what to do in a drug overdose emergency.
At the hospital, say you suspect medetomidine even if a test is negative. Medetomidine is not on typical rapid drug screens, and in the Philadelphia study of 209 patients, confirmatory testing found medetomidine metabolites in only 65 percent.
How does medically supervised withdrawal management work?
Withdrawal management means a clinician assesses the person, monitors them closely while symptoms are active, and treats symptoms as they arise. For opioid withdrawal that includes tracking vital signs and using medications chosen by a prescriber. When medetomidine may be involved, CDC notes that emerging guidance adds medications that calm the overactive stress response, sometimes by IV infusion in intensive care, with close tracking of heart rate and blood pressure. The specifics are decided by the treating prescriber, so this page gives no doses or schedules.
Level of care matters as much as the medications. Philadelphia’s health department recommends a lower threshold for sending outpatients to a higher level of care when symptoms are severe, and Canadian guidance lists severe hypertension, a racing heart, vomiting, and chest pain as reasons to transfer to an emergency department. An assessment by a nurse or physician, covering recent substances, vital signs, other health conditions, and the home environment, decides whether withdrawal management at home is appropriate. A responsible provider will say plainly when the answer is no.
| Talk with a nurse about whether withdrawal management at home fits your situation.
Free Consultation or call xxxxxxxxx |
Frequently asked questions
Is medetomidine withdrawal life-threatening?
It can be. CDC reports that severe medetomidine withdrawal can require emergency or intensive care and has been associated with heart attack and PRES. Not everyone develops severe withdrawal, but severe symptoms need urgent care.
How long does medetomidine withdrawal last?
Symptoms may begin within hours and peak 18 to 36 hours after the last use, per CDC. Interim guidance describes mild to moderate withdrawal lasting about 12 to 48 hours and severe withdrawal about 3 days, based on early evidence.
Does naloxone work on medetomidine?
Not on medetomidine sedation. It can restore breathing from opioids such as fentanyl, which are usually involved. Call 911 in case of any suspected overdose.
Is medetomidine the same as dexmedetomidine?
Medetomidine and dexmedetomidine are related, not identical. Dexmedetomidine is one of two mirror-image forms in medetomidine and is the form approved for hospital sedation. CDC reports illicit samples contain both forms.
Can medetomidine be detected on a drug test?
Medetomidine is not on typical hospital rapid screens. It needs specialized testing, and test strips can give false negatives, so a negative result does not rule it out.
Sources
Xylazine: Medical and Public Health Imperatives (ONDCP summary of the NEJM article, 2023)
MMWR Notes from the Field: Nitazene-Related Deaths, Tennessee, 2019 to 2021
Evidence note: most medetomidine findings come from hospital case series, retrospective studies, surveillance data, and federal advisories built on them. Case-report evidence is limited and guidance may change.